Agricultural Farm Products
Compare Stocks
4 / 10Stock Comparison
CHSCL vs BG vs ADM vs INGR
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Farm Products
Agricultural Farm Products
Packaged Foods
CHSCL vs BG vs ADM vs INGR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Agricultural Farm Products | Agricultural Farm Products | Agricultural Farm Products | Packaged Foods |
| Market Cap | — | $24.02B | $37.36B | $6.77B |
| Revenue (TTM) | $35.03B | $80.54B | $80.61B | $7.22B |
| Net Income (TTM) | $614M | $686M | $1.08B | $729M |
| Gross Margin | 3.2% | 5.2% | 5.8% | 25.3% |
| Operating Margin | 0.2% | 2.4% | 1.5% | 14.1% |
| Forward P/E | — | 14.4x | 18.6x | 9.6x |
| Total Debt | $3.23B | $16.95B | $8.41B | $1.79B |
| Cash & Equiv. | $399M | $1.14B | $1.01B | $1.03B |
CHSCL vs BG vs ADM vs INGR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CHS Inc. (CHSCL) | 100 | 95.8 | -4.2% |
| Bunge Global S.A. (BG) | 100 | 317.3 | +217.3% |
| Archer-Daniels-Midl… (ADM) | 100 | 197.2 | +97.2% |
| Ingredion Incorpora… (INGR) | 100 | 127.5 | +27.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHSCL vs BG vs ADM vs INGR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHSCL is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.10, Low D/E 29.1%, current ratio 1.53x
- Beta 0.10 vs INGR's 0.25, lower leverage
BG is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 32.4%, EPS growth -38.4%, 3Y rev CAGR 1.5%
- 32.4% revenue growth vs CHSCL's -9.7%
- +66.8% vs INGR's -18.4%
ADM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 31 yrs, beta 0.12, yield 2.6%
- 147.4% 10Y total return vs BG's 140.3%
- Beta 0.12, yield 2.6%, current ratio 11.20x
INGR carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (9.6x vs 14.4x)
- 10.1% margin vs BG's 0.9%
- 3.0% yield, 3-year raise streak, vs ADM's 2.6%, (1 stock pays no dividend)
- 9.4% ROA vs BG's 1.6%, ROIC 15.5% vs 3.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.4% revenue growth vs CHSCL's -9.7% | |
| Value | Lower P/E (9.6x vs 14.4x) | |
| Quality / Margins | 10.1% margin vs BG's 0.9% | |
| Stability / Safety | Beta 0.10 vs INGR's 0.25, lower leverage | |
| Dividends | 3.0% yield, 3-year raise streak, vs ADM's 2.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +66.8% vs INGR's -18.4% | |
| Efficiency (ROA) | 9.4% ROA vs BG's 1.6%, ROIC 15.5% vs 3.3% |
CHSCL vs BG vs ADM vs INGR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHSCL vs BG vs ADM vs INGR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INGR leads in 3 of 6 categories
BG leads 1 • CHSCL leads 1 • ADM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
INGR leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ADM is the larger business by revenue, generating $80.6B annually — 11.2x INGR's $7.2B. INGR is the more profitable business, keeping 10.1% of every revenue dollar as net income compared to BG's 0.9%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $35.0B | $80.5B | $80.6B | $7.2B |
| EBITDAEarnings before interest/tax | $471M | $2.8B | $3.0B | $1.2B |
| Net IncomeAfter-tax profit | $614M | $686M | $1.1B | $729M |
| Free Cash FlowCash after capex | $280M | $112M | $4.8B | $809M |
| Gross MarginGross profit ÷ Revenue | +3.2% | +5.2% | +5.8% | +25.3% |
| Operating MarginEBIT ÷ Revenue | +0.2% | +2.4% | +1.5% | +14.1% |
| Net MarginNet income ÷ Revenue | +1.8% | +0.9% | +1.3% | +10.1% |
| FCF MarginFCF ÷ Revenue | +0.8% | +0.1% | +6.0% | +11.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.6% | +87.8% | +1.6% | -2.4% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -76.4% | +1.6% | +79.0% |
Valuation Metrics
INGR leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 9.6x trailing earnings, INGR trades at a 72% valuation discount to ADM's 34.8x P/E. On an enterprise value basis, INGR's 6.0x EV/EBITDA is more attractive than BG's 22.6x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | — | $24.0B | $37.4B | $6.8B |
| Enterprise ValueMkt cap + debt − cash | — | $39.8B | $44.8B | $7.5B |
| Trailing P/EPrice ÷ TTM EPS | — | 25.16x | 34.77x | 9.61x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.38x | 18.63x | 9.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.57x |
| EV / EBITDAEnterprise value multiple | — | 22.60x | 17.18x | 5.98x |
| Price / SalesMarket cap ÷ Revenue | — | 0.34x | 0.47x | 0.94x |
| Price / BookPrice ÷ Book value/share | — | 1.18x | 1.63x | 1.60x |
| Price / FCFMarket cap ÷ FCF | — | — | 8.89x | 13.25x |
Profitability & Efficiency
INGR leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
INGR delivers a 17.1% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $4 for BG. CHSCL carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to BG's 0.97x. On the Piotroski fundamental quality scale (0–9), INGR scores 8/9 vs BG's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.5% | +4.3% | +4.7% | +17.1% |
| ROA (TTM)Return on assets | +3.0% | +1.6% | +2.2% | +9.4% |
| ROICReturn on invested capital | +0.5% | +3.3% | +3.3% | +15.5% |
| ROCEReturn on capital employed | +0.7% | +4.5% | +4.2% | +16.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 2 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.29x | 0.97x | 0.37x | 0.41x |
| Net DebtTotal debt minus cash | $2.8B | $15.8B | $7.4B | $760M |
| Cash & Equiv.Liquid assets | $399M | $1.1B | $1.0B | $1.0B |
| Total DebtShort + long-term debt | $3.2B | $17.0B | $8.4B | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | 5.03x | 3.10x | 3.03x | 27.32x |
Total Returns (Dividends Reinvested)
BG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BG five years ago would be worth $14,937 today (with dividends reinvested), compared to $12,144 for CHSCL. Over the past 12 months, BG leads with a +66.8% total return vs INGR's -18.4%. The 3-year compound annual growth rate (CAGR) favors BG at 13.5% vs INGR's 2.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.0% | +34.4% | +32.2% | -0.7% |
| 1-Year ReturnPast 12 months | +7.4% | +66.8% | +66.2% | -18.4% |
| 3-Year ReturnCumulative with dividends | +22.2% | +46.3% | +10.7% | +7.9% |
| 5-Year ReturnCumulative with dividends | +21.4% | +49.4% | +29.2% | +28.8% |
| 10-Year ReturnCumulative with dividends | +59.2% | +140.3% | +147.4% | +13.5% |
| CAGR (3Y)Annualised 3-year return | +6.9% | +13.5% | +3.4% | +2.6% |
Risk & Volatility
CHSCL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CHSCL is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than INGR's 0.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHSCL currently trades 98.5% from its 52-week high vs INGR's 75.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.10x | 0.25x | 0.12x | 0.25x |
| 52-Week HighHighest price in past year | $26.10 | $133.93 | $81.75 | $141.78 |
| 52-Week LowLowest price in past year | $25.15 | $71.60 | $46.81 | $100.71 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +92.4% | +94.8% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 57.0 | 51.8 | 68.4 | 27.3 |
| Avg Volume (50D)Average daily shares traded | 26K | 1.7M | 3.8M | 585K |
Analyst Outlook
Evenly matched — ADM and INGR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BG as "Buy", ADM as "Hold", INGR as "Hold". Consensus price targets imply 15.7% upside for INGR (target: $124) vs -22.6% for ADM (target: $60). For income investors, INGR offers the higher dividend yield at 3.01% vs BG's 2.23%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $133.67 | $60.00 | $124.25 |
| # AnalystsCovering analysts | — | 25 | 36 | 21 |
| Dividend YieldAnnual dividend ÷ price | — | +2.2% | +2.6% | +3.0% |
| Dividend StreakConsecutive years of raises | — | 5 | 31 | 3 |
| Dividend / ShareAnnual DPS | — | $2.76 | $2.04 | $3.24 |
| Buyback YieldShare repurchases ÷ mkt cap | — | +2.3% | 0.0% | +3.3% |
INGR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). BG leads in 1 (Total Returns). 1 tied.
CHSCL vs BG vs ADM vs INGR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHSCL or BG or ADM or INGR a better buy right now?
For growth investors, Bunge Global S.
A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -9. 7% for CHS Inc. (CHSCL). Ingredion Incorporated (INGR) offers the better valuation at 9. 6x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Bunge Global S. A. (BG) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHSCL or BG or ADM or INGR?
On trailing P/E, Ingredion Incorporated (INGR) is the cheapest at 9.
6x versus Archer-Daniels-Midland Company at 34. 8x. On forward P/E, Ingredion Incorporated is actually cheaper at 9. 6x.
03Which is the better long-term investment — CHSCL or BG or ADM or INGR?
Over the past 5 years, Bunge Global S.
A. (BG) delivered a total return of +49. 4%, compared to +21. 4% for CHS Inc. (CHSCL). Over 10 years, the gap is even starker: ADM returned +147. 4% versus INGR's +13. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHSCL or BG or ADM or INGR?
By beta (market sensitivity over 5 years), CHS Inc.
(CHSCL) is the lower-risk stock at 0. 10β versus Ingredion Incorporated's 0. 25β — meaning INGR is approximately 162% more volatile than CHSCL relative to the S&P 500. On balance sheet safety, CHS Inc. (CHSCL) carries a lower debt/equity ratio of 29% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHSCL or BG or ADM or INGR?
By revenue growth (latest reported year), Bunge Global S.
A. (BG) is pulling ahead at 32. 4% versus -9. 7% for CHS Inc. (CHSCL). On earnings-per-share growth, the picture is similar: Ingredion Incorporated grew EPS 15. 1% year-over-year, compared to -38. 9% for Archer-Daniels-Midland Company. Over a 3-year CAGR, BG leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHSCL or BG or ADM or INGR?
Ingredion Incorporated (INGR) is the more profitable company, earning 10.
1% net margin versus 1. 2% for Bunge Global S. A. — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INGR leads at 14. 4% versus 0. 3% for CHSCL. At the gross margin level — before operating expenses — INGR leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHSCL or BG or ADM or INGR more undervalued right now?
On forward earnings alone, Ingredion Incorporated (INGR) trades at 9.
6x forward P/E versus 18. 6x for Archer-Daniels-Midland Company — 9. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INGR: 15. 7% to $124. 25.
08Which pays a better dividend — CHSCL or BG or ADM or INGR?
In this comparison, INGR (3.
0% yield), ADM (2. 6% yield), BG (2. 2% yield) pay a dividend. CHSCL does not pay a meaningful dividend and should not be held primarily for income.
09Is CHSCL or BG or ADM or INGR better for a retirement portfolio?
For long-horizon retirement investors, Archer-Daniels-Midland Company (ADM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
12), 2. 6% yield, +147. 4% 10Y return). Both have compounded well over 10 years (ADM: +147. 4%, CHSCL: +59. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHSCL and BG and ADM and INGR?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CHSCL is a small-cap quality compounder stock; BG is a mid-cap high-growth stock; ADM is a mid-cap quality compounder stock; INGR is a small-cap deep-value stock. BG, ADM, INGR pay a dividend while CHSCL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 43%
- Dividend Yield > 0.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.